Participants showed improvements in fasting glucose, insulin resistance, blood pressure, and lipid levels alongside the weight loss
Albracht-SchulteKKalupahanaNRamalingamLWangSRahmanSRobert-McCombJet alOmega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update
The effect of liraglutide in NAFLD has also been compared to other antidiabetic drugs
Three of the trials included both placebo and active control groups, while others were either placebo- or active-controlled
In addition to chronic weight management, the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, when used with a reduced-calorie diet and increased physical activity
For the time being, though, the market is still dominated by two names: Eli Lilly and Co